Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/1/2021
SIETES contiene 93213 citas

 
 
 1 a 19 de 19 
Presentar resultados
Seleccionar todas
1. Cita con resumen
N.L.. Why gene-therapy drugs are so expensive. The Economist 2016:1. [Ref.ID 100562]
3.Tiene citas relacionadas
Kohn DB, Candotti F. Gene therapy fulfilling its promise. N Engl J Med 2009;360:518-21. [Ref.ID 85128]
4.Tiene citas relacionadas
Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo M-G. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009;360:447-58. [Ref.ID 85125]
5. Cita con resumen
Cole A. Child in gene therapy programme develops leukaemia. BMJ 2008;336:13. [Ref.ID 81950]
6.Tiene citas relacionadas Cita con resumen
Gaspar HB, Parsley K L, Howe S, King D, Gilmour K, Sinclair J, Brouns G, Schmidt M, Von Kalle C, Barington T, Jakobsen MA, Christensen HO, Ghonaium AA, White HN, Smith JL, Levinsky RJ, Ali RR, Kinnon C, Thrasher AJ. Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector. Lancet 2004;364:2181-7. [Ref.ID 72191]
7.Tiene citas relacionadas Cita con resumen
Cavazzana-Calvo M, Fischer A. Efficacy of gene therapy for SCID in being confirmed. Lancet 2004;364:2155-6. [Ref.ID 72181]
8.Tiene citas relacionadas Cita con resumen
Hescheler J, Welz A, Fleischmann BK. Searching for reputability: first randomised study on bone-marrow transplantation in the heart. Lancet 2004;364:121-2. [Ref.ID 70720]
9.Tiene citas relacionadas Cita con resumen
Antoine C, Müller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schutz A, Landais P, Fisher A, for the European Group for Blood and Marrow Transplantation and the European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003;361:553-60. [Ref.ID 65159]
10.Tiene citas relacionadas Cita con resumen
Buckley RH. Treatment options for genetically determined immunodeficiency. Lancet 2003;361:541-2. [Ref.ID 65155]
11. Cita con resumen
Anónimo. FDA halts gene therapy trials. Scrip 2003;2817:19. [Ref.ID 64834]
12.
Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000;343:1703-14. [Ref.ID 54339]
13.
Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000;343:1313-24. [Ref.ID 53518]
14.
Walther W, Stein U. Viral vectors for gene transfer: a review of their use in the treatment of human diseases. Drugs 2000;60:249-71. [Ref.ID 52253]
15.
Dobson R. Gene therapy saves immune deficient babies in France. BMJ 2000;320:1225. [Ref.ID 50755]
16.Tiene citas relacionadas
Matamoros Florí N, Milá Llambí J, Pons de Ves J. Imunodeficiencias primarias en España. Datos del Registro Español de Inmunodeficiencias Primarias. REDIP 1980-1999. Med Clin (Barc) 2000;114:96-100. [Ref.ID 49114]
17.Tiene citas relacionadas
Matamoros Florí N. Inmunodeficiencias primarias. Perspectivas actuales de diagnóstico y tratamiento. Med Clin (Barc) 2000;114:94-5. [Ref.ID 49113]
18.Tiene citas relacionadas
Fischer A. Thirty years of bone marrow transplantation for severe combined immunodeficiency. N Engl J Med 1999;340:559-61. [Ref.ID 42966]
19.Tiene citas relacionadas
Buckley RH, Schiff SE, Schiff RI, Markert ML, Williams LW, Roberts J L, Myers LA, Ward FE. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999;340:508-16. [Ref.ID 42959]
Seleccionar todas
 
 1 a 19 de 19